BOGOTA, Colombia – A new partnership aims to strengthen cancer registries throughout the region, as part of an effort to improve treatments and outcomes.

BOGOTA, Colombia – After years of delays on issuing a regulation for biosimilars, the Peruvian Directorate General of Medicines, Supplies and Drugs (Digemid) is moving forward with regulations that would pave the way for biosimilars to enter the Latin American country, but the pharma sector is concerned with the proposed timings for registration and re-registration of this relatively new category of drugs.

BOGOTA, Colombia – As it works to cut costs in the provision of health care, the government of Colombia is more aggressively enforcing price caps for drugs, and in particular, more expensive biologics.